CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Executive Summary 9

3 Introduction 14

3.1 GlobalData Report Guidance 14

4 Overview of the Pharmaceutical and Medical Device Markets 15

4.1 Pharmaceutical Market 15

4.1.1 Market Overview 15

4.1.2 Pharmaceutical Imports and Exports 19

4.1.3 Supply Channels 20

4.1.4 Market Segments 21

4.1.5 Overview of Major Therapeutic Areas 25

4.1.6 Overview of Major Drug Classes 27

4.1.7 Major Players 29

4.2 Medical Device Market 62

4.2.1 Market Overview 62

4.2.2 Overview of Top Five Segments 65

4.2.3 Major Players 76

4.3 Market Drivers and Barriers 101

4.3.1 Drivers 101

4.3.2 Barriers 102

5 Market Access 104

5.1 Reimbursement and Payer Landscape 104

5.1.1 Overview of Healthcare System 104

5.1.2 Drug Reimbursement Process 105

5.1.3 Medical Device and Diagnostics Reimbursement Process 108

5.1.4 Overview of Insurance Providers 110

5.1.5 Patient Share in Healthcare Spending 112

5.1.6 Price Trend in Healthcare Services 113

5.1.7 Pricing Policies 115

5.2 Regulatory Landscape 116

5.2.1 Overview of Regulatory Agencies 116

5.2.2 Market Authorization Procedure for Pharmaceutical Products 118

5.2.3 Market Authorization Procedure for Medical Devices 123

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 126

5.2.5 Licensing Process for Pharmaceutical Exports and Imports 127

5.2.6 Intellectual Property Rights 128

5.2.7 Clinical Trial Regulations 131

5.2.8 Pharmacy Regulations 134

5.2.9 Labeling and Packaging Regulations 135

6 Country Analysis 137

6.1 Political Environment 137

6.1.1 Political Structure 137

6.1.2 Analysis of the Current Political Environment 139

6.1.3 Healthcare Policy Initiatives 140

6.2 Economic Landscape 142

6.3 Economic Indicators 146

6.3.1 Gross Domestic Product 146

6.3.2 Gross National Income 150

6.3.3 Inflation 152

6.3.4 Currency Exchange Rate 154

6.3.5 Foreign Direct Investment 155

6.3.6 Foreign Exchange Reserves 156

6.3.7 Trade Balance 157

6.3.8 General Government Structural Balance 159

6.3.9 General Government Net Debt 160

6.3.10 Major Industries 161

6.4 Demographics 163

6.4.1 Population 163

6.4.2 Urban-Rural Share 165

6.4.3 Distribution by Age Group 166

6.4.4 Birth Rate 168

6.4.5 Mortality 169

6.4.6 Causes of Mortality 170

6.4.7 Health Status by Gender and Age 171

6.4.8 Education and Literacy 179

6.4.9 Employment 181

6.4.10 Disease Burden 182

6.5 Healthcare Infrastructure 185

6.5.1 Healthcare Facilities 185

6.5.2 Healthcare Parameters 187

6.5.3 Environmental Health 190

6.5.4 Healthcare Personnel 193

6.6 Healthcare Expenditure 197

6.6.1 Overview 197

6.6.2 Public-Private Sector Share 200

6.6.3 Major Components of Healthcare Spending 201

6.6.4 Spending in Science and Technology Research and Development 203

6.7 Trade Associations 204

6.7.1 Canadian Pharmacists Association (CPhA) 204

6.7.2 Canadian Association of Professional Regulatory Affairs 204

6.7.3 Canadian Society for Hospital Pharmacists 204

6.7.4 Canadian Generic Pharmaceutical Association 204

6.8 Trade Fairs 205

7 Opportunities and Challenges 206

7.1 Opportunities 206

7.2 Challenges 206

8 Appendix 208

8.1 Abbreviations 208

8.2 Bibliography 213

8.3 Research Methodology 225

8.3.1 Coverage 226

8.3.2 Secondary Research 226

8.3.3 Forecasts 227

8.3.4 Expert Panel 227

8.4 Contact Us 227

8.5 Disclaimer 228

1.1 List of Tables

Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016 16

Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021 17

Table 3: Pharmaceutical Market, Canada, Pharmaceutical Spending (% of health spending), 2009-2015 18

Table 4: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016 20

Table 5: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016 22

Table 6: Pharmaceutical Market, Biologics, Canada, Approved Biologics, 2016 23

Table 7: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016 24

Table 8: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015 26

Table 9: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015 29

Table 10: Pharmaceutical Market, Johnson & Johnson, Canada, Major Products, 2016 30

Table 11: Pharmaceutical Market, Johnson & Johnson, Planned Filings, 2017-2020 32

Table 12: Pharmaceutical Market, Novartis, Canada, Major Products, 2017 40

Table 13: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020 42

Table 14: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2017 48

Table 15: Pharmaceutical Market, Gilead, Major Products, 2017 57

Table 16: Pharmaceutical Market, Gilead, Global, Late-Stage Pipeline, 2017 58

Table 17: Medical Device Market, Canada, Revenue ($bn), 2009-2016 63

Table 18: Medical Device Market, Canada, Revenue Forecast ($bn), 2017-2021 64

Table 19: Medical Device Market, Canada, Revenue ($bn) and Market Share ($bn) by Segment, 2016 65

Table 20: Orthopedic Devices Market, Canada, Revenue ($bn), 2009-2016 66

Table 21: Orthopedic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016 67

Table 22: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009-2016 68

Table 23: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016 69

Table 24: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009-2016 70

Table 25: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016 71

Table 26: Cardiovascular Devices Market, Canada, Revenue of Major Players ($m), 2009-2016 72

Table 27: IVD Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2015 73

Table 28: IVD Market, Canada, Revenue ($bn), 2009-2016 74

Table 29: Healthcare IT Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016 75

Table 30: Medical Device Market, Canada, Revenue ($m) of Major Companies, 2012 76

Table 31: Medical Device Market, Johnson & Johnson, Major Medical Device Sales, 2016 77

Table 32: Medical Device Market, Medtronic, Major Products, 2016 82

Table 33: Medical Device Market, Baxter, Global, Major Products, 2017 89

Table 34: Medical Device Market, Fresenius Medical Care, Global, Major Products, 2016 94

Table 35: Medical Device Market, Sonova, Global, Major Products, 2017 99

Table 36: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009-2016 112

Table 37: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009-2015 113

Table 38: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009-2015 114

Table 39: Market Access, Target Review Times for New Drug Submissions, Canada, 2016 120

Table 40: Market Access, Classes of Medical Devices, 2016 124

Table 41: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009-2016 147

Table 42: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017-2021 148

Table 43: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009-2016 149

Table 44: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 150

Table 45: Economic Indicators, Canada, Gross National Income per Capita ($), 2009-2016 151

Table 46: Economic Indicators, Canada, Average Consumer Price Index, 2009-2016 152

Table 47: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009-2016 153

Table 48: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009-2016 154

Table 49: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009-2015 155

Table 50: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009-2016 156

Table 51: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009-2016 157

Table 52: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009-2016 158

Table 53: Economic Indicators, Canada, Government Structural Balance ($bn), 2009-2016 159

Table 54: Economic Indicators, Canada, General Government Net Debt ($bn), 2009-2016 160

Table 55: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016 162

Table 56: Demographics, Canada, Population (million), 2009-2016 163

Table 57: Demographics, Canada, Population (million), 2017-2021 164

Table 58: Demographics, Canada, Urban-Rural Population Share (%), 2009-2016 165

Table 59: Demographics, Canada, Population Distribution by Age Group (%), 2009-2016 166

Table 60: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017-2021 167

Table 61: Demographics, Canada, Births (per 1,000 population), 2009-2015 168

Table 62: Demographics, Canada, Mortality (per 1,000 population), 2009-2015 169

Table 63: Demographics, Canada, Major Causes of Mortality, 2015 171

Table 64: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009-2016 172

Table 65: Demographics, Canada, Immunization Rate (%), 2009-2016 173

Table 66: Demographics, Canada, Major Causes of Male Mortality, 2015 175

Table 67: Demographics, Canada, Major Causes of Female Mortality, 2015 176

Table 68: Demographics, Canada, Gender Ratio (M/F), 2009-2016 177

Table 69: Demographics, Canada, Life Expectancy at Birth (years), 2009-2016 179

Table 70: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009-2015 180

Table 71: Demographics, Canada, Unemployment Rate (%), 2009-2016 181

Table 72: Demographics, Canada, Most Frequently Diagnosed Diseases (‘000), 2015 183

Table 73: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015 184

Table 74: Healthcare Infrastructure, Canada, Number of Hospitals, 2009-2015 185

Table 75: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009-2015 186

Table 76: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009-2015 187

Table 77: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009-2015 188

Table 78: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009-2015 189

Table 79: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009-2015 191

Table 80: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009-2015 192

Table 81: Healthcare Infrastructure, Canada, Physicians (per 1,000 population), 2009-2015 193

Table 82: Healthcare Infrastructure, Canada, Dentists, 2009-2015 194

Table 83: Healthcare Infrastructure, Canada, Pharmacists, 2009-2015 195

Table 84: Healthcare Infrastructure, Canada, Nurses (per 1,000 population), 2009-2015 196

Table 85: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 198

Table 86: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014-2019 199

Table 87: Healthcare Expenditure, Canada, Public-Private Share (%), 2009-2015 200

Table 88: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014 201

Table 89: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016 202

Table 90: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009-2015 203

Table 91: Healthcare Expenditure, Canada, Major Healthcare Trade Fairs, 2017 205

1.2 List of Figures

Figure 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2021 10

Figure 2: Medical Device Market, Canada, Revenue ($bn), 2009-2021 11

Figure 3: Country Profile, Canada, 2017 13

Figure 4: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016 16

Figure 5: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021 17

Figure 6: Pharmaceutical Market, Canada, Pharmaceutical Spending as Percentage of Health Spending (%), 2009-2015 18

Figure 7: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016 19

Figure 8: Pharmaceutical Market, Canada, Supply Channels, 2016 21

Figure 9: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016 22

Figure 10: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016 24

Figure 11: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class, 2015 25

Figure 12: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015 28

Figure 13: Medical Device Market, Canada, Revenue ($bn), 2009-2016 63

Figure 14: Medical Device Market, Canada, Revenue Forecast ($bn), 2017-2021 64

Figure 15: Medical Device Market, Canada, Revenue by Segment ($bn), 2016 65

Figure 16: Orthopedic Devices Market, Canada, Revenue ($bn), 2009-2016 66

Figure 17: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2016 67

Figure 18: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009-2016 68

Figure 19: Ophthalmic Devices Market, Canada, Market Share of Major Players (%), 2016 69

Figure 20: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009-2016 70

Figure 21: Drug Delivery Devices Market, Canada, Market Share of Major Players (%), 2016 71

Figure 22: In Vitro Diagnostics Market, Canada, Revenue ($bn), 2009-2016 72

Figure 23: In Vitro Diagnostics Market, Canada, Market Share of Major Players (%), 2015 73

Figure 24: Healthcare IT Market, Canada, Revenue ($bn), 2009-2016 74

Figure 25: Healthcare IT Market, Canada, Market Share of Major Companies (%), 2016 75

Figure 26: Medical Device Market, Canada, Revenue of Major Companies ($m), 2012 76

Figure 27: Pharmaceutical Market, Canada, Drivers and Barriers, 2017 103

Figure 28: Market Access, Canada, Reimbursement Process, 2017 107

Figure 29: Market Access, Canada, Medical Device and Diagnostics Reimbursement Process, 2017 109

Figure 30: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009-2016 112

Figure 31: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009-2015 113

Figure 32: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009-2015 114

Figure 33: Health Products and Food Branch, Organization Chart, Canada, 2015 117

Figure 34: New Drug Approval Process, Canada, 2017 122

Figure 35: Patent Approval Process, Canada, 2015 130

Figure 36: Clinical Trial Regulation Process, Canada, 2016 133

Figure 37: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009-2016 147

Figure 38: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017-2021 148

Figure 39: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009-2016 149

Figure 40: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 150

Figure 41: Economic Indicators, Canada, Gross National Income per Capita ($), 2009-2016 151

Figure 42: Economic Indicators, Canada, Average Consumer Price Index, 2009-2016 152

Figure 43: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009-2016 153

Figure 44: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009-2016 154

Figure 45: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009-2015 155

Figure 46: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009-2016 156

Figure 47: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009-2016 157

Figure 48: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009-2016 158

Figure 49: Economic Indicators, Canada, Government Structural Balance ($bn), 2009-2016 159

Figure 50: Economic Indicators, Canada, General Government Net Debt ($bn), 2009-2016 160

Figure 51: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016 161

Figure 52: Demographics, Canada, Population (million), 2009-2016 163

Figure 53: Demographics, Canada, Population (million), 2017-2021 164

Figure 54: Demographics, Canada, Urban-Rural Population Share (%), 2009-2016 165

Figure 55: Demographics, Canada, Population Distribution by Age Group (%), 2009-2016 166

Figure 56: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017-2021 167

Figure 57: Demographics, Canada, Births (per 1,000 population), 2009-2015 168

Figure 58: Demographics, Canada, Mortality (per 1,000 population), 2009-2015 169

Figure 59: Demographics, Canada, Major Causes of Mortality, 2015 170

Figure 60: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009-2016 172

Figure 61: Demographics, Canada, Immunization Rate (%), 2009-2016 173

Figure 62: Demographics, Canada, Major Causes of Male Mortality, 2015 174

Figure 63: Demographics, Canada, Major Causes of Female Mortality, 2015 176

Figure 64: Demographics, Canada, Gender Ratio (M/F), 2009-2016 177

Figure 65: Demographics, Canada, Life Expectancy at Birth (years), 2009-2016 178

Figure 66: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009-2015 180

Figure 67: Demographics, Canada, Unemployment Rate (%), 2009-2016 181

Figure 68: Demographics, Canada, Patients (‘000s), 2015-2016 182

Figure 69: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015 184

Figure 70: Healthcare Infrastructure, Canada, Number of Hospitals, 2009-2015 185

Figure 71: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009-2015 186

Figure 72: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009-2015 187

Figure 73: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009-2015 188

Figure 74: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009-2015 189

Figure 75: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009-2015 191

Figure 76: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009-2015 192

Figure 77: Healthcare Infrastructure, Canada, Physicians, 2009-2015 193

Figure 78: Healthcare Infrastructure, Canada, Dentists, 2009-2015 194

Figure 79: Healthcare Infrastructure, Canada, Pharmacists, 2009-2015 195

Figure 80: Healthcare Infrastructure, Canada, Nurses, 2009-2015 196

Figure 81: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 198

Figure 82: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014-2019 199

Figure 83: Healthcare Expenditure, Canada, Public-Private Share (%), 2009-2015 200

Figure 84: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014 201

Figure 85: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016 202

Figure 86: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009-2015 203

Figure 87: Healthcare Market, Canada, Opportunities and Challenges, 2017 207

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada

Summary

Canada is a mature healthcare market, with a strong focus on pharma R&D and a high level of total healthcare expenditure that is 11% of its Gross Domestic Product (GDP). The increasing elderly population and its associated disease burden are expected to drive the growth of the pharmaceutical market, while government initiatives to reduce healthcare expenditure may limit growth. The value of the Canadian pharmaceutical market increased from US$19.6 Billion in 2009 to US$22.6 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of 2%. The market value is expected to reach US$25 Billion in 2021.

In 2016, the value of the generic pharmaceutical market was US$6.16 Billion. In 2016, generic drugs accounted for 70.2% of prescriptions in Canada, compared with 89% in the US. However, generic drug sales account for only 22.4% of the US$25.1 Billion pharmaceutical market. The use of generic medicines saved nearly US$20 Billion for the government in 2016. The generics market is expected to continue to grow as the government promotes generics usage and as quality perception improves among patients.

In 2016 healthcare expenditure in Canada stood at US$228.1 Billion, an increase of US$44.8 Billion from 2015. In 2009, the healthcare expenditure as a percentage of GDP was 11.6%, which decreased to an estimated 11.1% in 2016. In 2009, health expenditure per capita was approximately US$4,497, which increased to an estimated US$6,299 in 2016. The increasingly elderly population and associated disease burden have been driving the growth of the pharmaceutical market. In 2016, the elderly population accounted for 17% of the total population, and this is expected to increase at a CAGR of 3.7% to 20% by 2021.

Canadian medical device market was valued at US$8.6 Billion in 2009, which increased to US$10.5 Billion in 2016, and it is expected to grow at a CAGR of 4.2% from US$11.4 Billion in 2017 to US$13.4 Billion in 2021. The main segments were ophthalmic devices, orthopedic devices, drug delivery devices, in vitro diagnostics and healthcare IT.

The report CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Canada.

In particular, this report provides the following analysis -

• Provides an overview of the Canadian healthcare market and its key driving factors. It also gives a snapshot of the demographic, regulatory, and reimbursement landscape and healthcare infrastructure in Canada.
• Provides an overview of the Canadian pharmaceutical and medical device markets, covering market size; the market shares of generic, Over-the-Counter (OTC) and biologic/biosimilar products; and the key drivers and barriers for the overall market. It also includes profiles of the major players, as well as SWOT assessments.
• Covers the reimbursement and payer landscape, and includes details of the reimbursement process, insurance providers, pricing policies and drug price trends in Canada.
• Provides detailed analysis of the political and economic environment in Canada, and analyses economic indicators, demographics, and healthcare infrastructure and expenditure.
• Provides an overview of the opportunities for and challenges to growth in the Canadian healthcare market.

Companies mentioned in this report: Johnson & Johnson, Novartis, Teva, Apotex, Gilead.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
• Profiles and SWOT analyses of the major players in the pharmaceutical market (Johnson & Johnson, Novartis, Teva, Apotex and Gilead) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter, Fresenius and Sonova)
• An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
• Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
• An overview of the opportunities for and challenges to growth in the Canadian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Canadian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
• Identify, understand, and capitalize on the opportunities and challenges in the Canadian healthcare market